Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 3,025-3,036 of 4,306
Other study type icon
CompletedNCT00774085

Treatment & Outcomes Data for Schizophrenia

This study is completed. It is testing treatment & Outcomes Data for Schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.
Countries
Sponsor
Janssen Cilag N.V./S.A.
Condition
Schizophrenia
Other study type icon
CompletedNCT05042739

Early Identification and Predictive Parsing for High Risk Group of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Wuhan
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDiagnostic TestA study that looks at how to detect, measure, or better understand a condition.
Countries
China
Sponsor
Wuhan Mental Health Centre
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2013-000415-25

A randomized, double-blind, placebo controlled study to evaluate the efficacy and safety of Naproxen, Simvastatin and their combination, compared to placebo as add-on to anti-psychotics in the trea...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Romania
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Romania
Sponsor
Clinirx Tangent Research
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2004-000870-29

CONSTATRE Risperdal Consta Trial of Relapse Prevention and Effectiveness

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Austria
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Austria, Czechia, Hungary, ...
Sponsor
Janssen-Cilag Medical Affairs EMEA
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2013-000338-37

Evaluation of the necessity of a pharmacological treatment with antipsychotics for the prevention of relapse in long-term stabilized schizophrenic patients: a randomized, single-blind, longitudinal...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Germany
Sponsor
Technische Universität München, vertreten durch das Klinikum rechts der Isar
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2005-005343-26

Open-Label Study to Evaluate the Safety and Pharmacokinetics of Single-and Multiple-Dose Extended-Release OROS Paliperidone in Pediatric Subjects (>/= 10 to

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Belgium
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Belgium, Finland
Sponsor
Janssen-Cilag International N.V.
Condition
Schizophrenia
Other study type icon
Not recruitingISRCTN21059161

Population-based Outreach Services to Reduce Homelessness among Veterans with serious mental illness (SMI)

This study is looking at whether Standard REP included the initial Implementation phase of Re-Engage, specifically: 1 can help people with Serious mental illnesses including schizophrenia, bipolarity, and schizoaffective disorder, Mental and Behavioural Disorders, or Schizophrenia, Bipolarity. Participants take part in Standard REP included the initial Implementation phase of Re-Engage, specifically: 1 and complete follow-up assessments.

In United States
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, BipolarityOther
Countries
United States
Sponsor
VA Health Services Research & Development (USA)
Condition
Schizophrenia, Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.